Monotherapy of experimental metabolic syndrome: I. Efficacy and safety
Authors
Štefan Bezek
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
Zuzana Brnoliaková
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
Ružena Sotníková
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
Vladimír Knezl
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
Ema Paulovičová
Institute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovakia
Jana Navarová
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
Viktor Bauer
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
Language: English
Page range: 81 - 85
Submitted on: Sep 12, 2017
Accepted on: Oct 15, 2017
Published on: Feb 14, 2018
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2018 Štefan Bezek, Zuzana Brnoliaková, Ružena Sotníková, Vladimír Knezl, Ema Paulovičová, Jana Navarová, Viktor Bauer, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.